November 2002
Worldwide Biotech;Nov2002, Vol. 14 Issue 11, p3
Trade Publication
Provides information on the novel insulin therapy for type diabetes developed by BTG, a global technology commercialization company.


Related Articles

  • SYMPOSIUM. Important updates on the management of inpatient hyperglycemia: Practical implications for pharmacists. Moghissi, Etie S. // American Journal of Health-System Pharmacy;8/15/2010, Vol. 67 Issue 16, pS2 

    An introduction to the journal is presented in which the editor discusses the article "Reexamining the Evidence for Inpatient Glucose Control: New Recommendations for Glycemic Targets," "Ensuring Optimal Insulin Utilization in the Hospital Setting: Role of the Pharmacist," by Dr. Janet Kelly,...

  • Toward an ouchless way to take insulin.  // Countdown;Winter96, Vol. 17 Issue 1, p12 

    Reports on attempts to develop a pocket-size device that could both monitor blood sugar and give insulin to diabetics without using a needle. Use of ultrasound to help insulin penetrate the skin without a needle; How the process works; Researchers at the Massachusetts Institute of Technology...

  • Insulin Therapy for Diabetes: Is the Future Now? Hirsch, Irl B. // Clinical Diabetes;Fall2001, Vol. 19 Issue 4, p146 

    Focuses on insulin therapy for diabetes patients in the United States. Use of insulin to minimize risk of hypoglycemia; Problems associated with insulin therapy; Recommendations for the betterment of the study and practice of insulin therapy.

  • Second opinion.  // Mayo Clinic Health Letter;Jul1996, Vol. 14 Issue 7, p8 

    Presents an answer to a query related to the effect of heat on the insulin needs of a diabetic. Changes in diet and activity level; Hypoglycemia.

  • Correction: Efficacy and Safety of Inhaled Insulin Therapy.  // Annals of Internal Medicine;5/16/2006, Vol. 144 Issue 10, p783 

    A correction to an article regarding efficacy and safety of inhaled insulin therapy, published in a previous issue is presented.

  • Diabetics prefer pre-mixed insulins in pen syringes.  // Modern Medicine;Jan95, Vol. 63 Issue 1, p48 

    Presents an abstract of the article `Premixed Insulin Preparations in Pen Syringes Maintain Glycemic Control and Are Preferred by Patients,' by J.M. Dunbar, T.M. Fiad et al from Diabetes Care dated August 1994.

  • Taking control of diabetes. Abramovitz, Melissa // Current Health 2;Jan1999, Vol. 25 Issue 5, p19 

    Reports on the control of diabetes in the United States. Prevalence of the disease; Types of diabetes; Treatment programs; Therapeutic action of insulin; Efforts to develop drugs to help control diabetes.

  • Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus. Dunn, C.J.; Plosker, G.L.; Dunn, Christopher J; Plosker, Greg L // PharmacoEconomics;2002, Vol. 20 Issue 14, p989 

    Unlabelled: Insulin lispro is a recombinant insulin analogue with transposed amino acids (proline and lysine) at positions 28 and 29 near the C-terminus of the B-chain. The most prominent practical advantage of insulin lispro over human soluble insulin lies in its very rapid onset...

  • The Effect of Adiposity on Insulin Pharmacodynamics.  // Neurology Alert;Feb2012 Clinical Brief, p2 

    The article discusses research on the interrelatedness of adiposity and the effectiveness of insulin therapy to obese patients, referencing a study by F. Porcellati, et al, published in a 2011 issue of "Diabetes Care."


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics